바이오인

 

 

This year’s Pharmaceutical Industry Profile spotlights the significant value the biopharmaceutical research sector and its products represent for Americans and the American economy.  Learn more about the unprecedented potential of today’s science as well as the challenges facing pharmaceutical research companies in 2009.

 

 

Introduction

Biopharmaceutical Research Companies’ Impact: Value for Americans. .  v
Innovation Drives Value. . . . . . . . . . . . . . . . . . . . . . . . . .  vi
Value for Patients: Longer Lives, Better Health. . . . . . . . . . 1
Increasing Life Expectancy. . . .  2
Decreasing Disability. . . .  . . .   . . . 4
Reducing the Need for Health Services . . .  5
Value for the Economy: A Source of Strength in Difficult Times. . . . . . . .  9
Employing Americans . . .  11
Bolstering the Economy . . . . . . . . . .  12
Value for Health Care: Policies That Improve Patient Access. . .  15
Access to Health Insurance . . .  16
Access to Medicines. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  18
Value for Preventing Disease: Lower Burden of Chronic Illness. . .  25
The Problem: Chronic Disease Is Increasing . . . . . . . . . . . . .  26
The Prevention Gap. . . . . . . . . . . . . . . . . . . . . . . . . . . . .  26
The Value of Prevention. . . . . . . . . . . . . . . . . . . . . . . . . .  28
Closing the Prevention Gap. . .  29
Value for the Future: R&D Promise and Challenges. . .  31
Future Value: Science and Technology Opportunities. . . . . . . . . .  34
Personalized Medicine. . . . . . . . . . . .  34
Medicines Currently in Development. . .  35
Today’s Pharmaceutical R&D Process: Long, Increasingly Complex and Costly. . .  36
Conclusion
Policies That Support Research Promote Value for Americans. . .  41
Appendix. . . . . . . . . 43
Member Companies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  44
PhRMA Annual Membership Survey Definitions of Terms. . .  47
List of Tables: Detailed Results from the PhRMA Annual Membership Survey. . .  49